Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Inventory (2023 - 2025)

BrightSpring Health Services' Inventory history spans 3 years, with the latest figure at $815.2 million for Q4 2025.

  • For Q4 2025, Inventory rose 28.06% year-over-year to $815.2 million; the TTM value through Dec 2025 reached $815.2 million, up 28.06%, while the annual FY2025 figure was $815.2 million, 28.06% up from the prior year.
  • Inventory reached $815.2 million in Q4 2025 per BTSG's latest filing, up from $639.2 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $815.2 million in Q4 2025 to a low of $373.7 million in Q1 2024.
  • Average Inventory over 3 years is $542.1 million, with a median of $533.6 million recorded in 2025.
  • The largest YoY upside for Inventory was 67.11% in 2025 against a maximum downside of 28.06% in 2025.
  • A 3-year view of Inventory shows it stood at $402.8 million in 2023, then soared by 58.04% to $636.6 million in 2024, then increased by 28.06% to $815.2 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Inventory are $815.2 million (Q4 2025), $639.2 million (Q3 2025), and $625.5 million (Q2 2025).